Avantor, Inc. (NYSE:AVTR) Shares Acquired by First Hawaiian Bank

First Hawaiian Bank boosted its position in shares of Avantor, Inc. (NYSE:AVTR - Free Report) by 28.7% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 109,100 shares of the company's stock after purchasing an additional 24,342 shares during the period. First Hawaiian Bank's holdings in Avantor were worth $2,299,000 as of its most recent SEC filing.

Several other hedge funds also recently added to or reduced their stakes in the company. Candriam S.C.A. lifted its stake in shares of Avantor by 7.6% during the 2nd quarter. Candriam S.C.A. now owns 57,424 shares of the company's stock worth $1,217,000 after acquiring an additional 4,046 shares during the last quarter. Quest Partners LLC bought a new stake in Avantor during the 2nd quarter valued at about $229,000. Choreo LLC purchased a new stake in Avantor in the 2nd quarter valued at about $868,000. Royal London Asset Management Ltd. grew its stake in Avantor by 6.7% in the 2nd quarter. Royal London Asset Management Ltd. now owns 250,308 shares of the company's stock worth $5,307,000 after acquiring an additional 15,813 shares in the last quarter. Finally, Andra AP fonden increased its position in shares of Avantor by 3.5% during the second quarter. Andra AP fonden now owns 395,900 shares of the company's stock worth $8,393,000 after acquiring an additional 13,400 shares during the period. 95.08% of the stock is currently owned by institutional investors.

Analyst Upgrades and Downgrades

AVTR has been the subject of a number of research reports. Royal Bank of Canada reiterated an "outperform" rating and issued a $34.00 price target on shares of Avantor in a report on Thursday, September 26th. Robert W. Baird lowered their target price on Avantor from $27.00 to $26.00 and set an "outperform" rating for the company in a report on Monday, October 28th. UBS Group cut their price target on Avantor from $30.00 to $29.00 and set a "buy" rating on the stock in a research note on Tuesday, October 8th. Barclays lowered their price objective on shares of Avantor from $28.00 to $25.00 and set an "overweight" rating for the company in a research note on Friday, October 25th. Finally, Wells Fargo & Company cut their target price on shares of Avantor from $30.00 to $28.00 and set an "overweight" rating on the stock in a research report on Monday, October 28th. Two analysts have rated the stock with a hold rating and eleven have assigned a buy rating to the stock. Based on data from MarketBeat.com, the company currently has an average rating of "Moderate Buy" and a consensus price target of $27.69.

Avantor Stock Up 0.6 %

Shares of AVTR stock traded up $0.14 during trading hours on Thursday, reaching $22.13. 2,970,094 shares of the company's stock were exchanged, compared to its average volume of 3,195,679. The company has a current ratio of 1.54, a quick ratio of 1.06 and a debt-to-equity ratio of 0.84. The company has a market cap of $15.06 billion, a price-to-earnings ratio of 48.11, a P/E/G ratio of 2.75 and a beta of 1.28. Avantor, Inc. has a fifty-two week low of $19.59 and a fifty-two week high of $28.00. The stock's 50 day moving average is $21.53 and its 200-day moving average is $23.34.

About Avantor

Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.